| Type | Title | Date Released | |
|---|---|---|---|
6-K | Cardiol Therapeutics Enters Into $75 Million Open Market Sale Agreement with Jefferies | ||
6-K | Cardiol Therapeutics Announces At-The-Market Equity Offering Program With Jefferies LLC | ||
SUPPL | November 2026 ATM | Offering amount: $75,000,000 | Bank: Jefferies LLC | ||
SCHEDULE 13G/A | Tejara Capital Ltd (Filed by) | ||
6-K | Cardiol Therapeutics Achieves Phase III MAVERIC Enrollment Target Ahead of Schedule and Expands Pivotal Trial | ||
SUPPL | Form SUPPL | ||
F-10/A | September 2026 SHELF | ||
6-K | Cardiol Therapeutics Announces Warrant Exercise for Over USD $7 Million in Proceeds and Extension of Cash Runway | ||
6-K | Cardiol Therapeutics Inc. Code of Business Conduct and Ethics | ||
6-K | Master Services Agreement between Cardiol Therapeutics and Dalton Pharma Services | ||
6-K | Cardiol Therapeutics Files US$150 Million Preliminary Base Shelf Prospectus Following OSC Review | ||
F-X | Form F-X |
